Tristel Plc · LSE:TSTL
Tristel — FY2019 Earnings Presentation
21 slides from Tristel's earnings presentation, Jun 30, 2019
Slide 1: Preliminary Results Investor Presentation
Tristel 30 JUNE 19 PRELIMINARY RESULTS INVESTOR PRESENTATION PAUL SWINNEY, CEO LIZ DIXON, FD
Slide 2: Who We Are
WHO WE ARE UNIQUE SELLING POINTS MULTIPLE USE SITES
Slide 3: Financial Highlights
FINANCIAL HIGHLIGHTS • • • • • • • • • 3
Slide 4: Financial Targets
FINANCIAL TARGETS £27,000,000 £25,000,000 £23,000,000 £21,000,000 £19,000,000 £17,000,000 £15,000,000 2015-16 2016-17 2017-18 2018-19
Slide 5: Key Dynamics
KEY DYNAMICS £30,000,000 • £25,000,000 • • £20,000,000 • • £15,000,000 £10,000,000 £5,000,000 £0 2015-16 2016-17 2017-18 2018-19 5
Slide 6: Key Dynamics
Tristel £,000 UK Human healthcare Intl Human healthcare Medical device disinfection Critical surface disinfection Other Medical device disinfection Critical surface disinfection Other Animal healthcare Contamination control Total revenue KEY DYNAMICS 2012-13 2013-14 =. 2014-15 =: 2015-16 2,965 4,253
Slide 7: Geographical Expansion
Tristel GEOGRAPHICAL EXPANSION [Bl Active Global subsidiaries [BB epprovais in process) Global Subsidiaries [BB ctobat oistributors
Slide 8: Sales Growth by Geography
Tristel SALES GROWTH BY GEOGRAPHY Year on % Change year in constant £,000 2016-17 2017-18 2018-19 change %Change currency Central & Eastern Europe 3,321 4,186 4,610 424 10% 11% Western Europe - - 2,140 2,140 - - Australasia 2,595 3,066 3,299 233 8% 11% Hong Kong 588 394 979 585 148% 139% China 524 6
Slide 9: Long Term Growth Potential
LONG TERM GROWTH POTENTIAL MEDICAL DEVICES SURFACES DEFENSIVE STRENGTHS • o o • o o o o HLD • Semi-Critical • Classification • o Invasive Device o 9
Slide 10: ClO2 Medical Device Disinfection Sales by Application 2018-19
ClO2 MEDICAL DEVICE DISINFECTION SALES BY APPLICATION* 2018-19 → 10
Slide 11: Long Term Growth Potential USA
LONG TERM GROWTH POTENTIAL USA • o o o • • • 11
Slide 12: Investments and Cashflow
INVESTMENTS AND CASHFLOW 2018-19 2017-18 £,000 £,000 Net cash from operations 5,877 4,918 Decrease in cash during the year (2,509) (1,587) 12
Slide 13: Operational Highlights
OPERATIONAL HIGHLIGHTS • o o o • • o o • • 13
Slide 14: Summary
Tristel SUMMARY Overseas expansion, both organic and acquired, continues to drive sales growth * Continued profits growth and cash generation. Company remains debt-free * Business has strong IP and many defensive strengths * Exciting new market opportunities ahead * Further sustainable growth to com
Slide 15: Thank You
THANK THANKYOU YOU
Slide 16: Appendix – Income Statement
APPENDIX – INCOME STATEMENT £’000 £’000 Cost of sales (5,504) (5,040) Administrative expenses (13,579) (10,971) Net interest 4 2 Results from associate 45 24 Operating profit before amortisation & shared based payments 7,135 6,235 Amortisation & Depreciation (1,537) (1,564) Share based payments (852
Slide 17: Appendix – Balance Sheet
APPENDIX – BALANCE SHEET Non-current assets £’000 £’000 Goodwill 5,150 998 Investments 872 589 Intangible assets 7,593 5,954 Property, plant and equipment 1,466 1,328 Current assets Inventories 3,077 2,279 Trade and other receivables 5,250 4,332 Cash and cash equivalents 4,170 6,661 Continued… 17
Slide 18: Appendix – Balance Sheet Continued
APPENDIX – BALANCE SHEET CONTINUED £’000 £’000 Capital and reserves Share capital 446 432 Share premium account 11,427 11,058 Merger reserve 2,205 478 Foreign exchange reserve 83 (66) Retained earnings 9,191 6,518 Non-controlling interests 7 7 Current liabilities Trade and other payables 3,539 3,201
Slide 19: Appendix – Cash Flow Reconciliation
APPENDIX – CASH FLOW RECONCILIATION £’000 £’000 Profit before tax 4,746 4,006 Add back non-cash items 2,405 2,135 Working capital movements (779) (520) Purchase of tangible fixed assets (678) (516) Purchase of intangible assets (669) (997) Purchase of investments (4,826) - Proceeds from sale of prop
Slide 20: Glossary
Tristel HLD or High-level disinfectant ClO2 or Chlorine dioxide MD or Medical device Core GLOSSARY A globally recognised classification for a disinfectant that can kill all micro- organisms including large numbers of bacterial spores (but not necessarily all). Tristel owns a proprietary formulation
Slide 21: Tristel – We Have Chemistry
Tristel WE HAVE CHEMISTRY.